President Trump unveiled four executive orders on drug pricing 24 July, including a directive to advance international reference pricing for lowering Medicare Part B drug costs unless industry offers an alternative solution in the next 30 days to “end foreign free-riding.”
The orders were announced to bolster the Administration’s record on lowering drug pricing as the presidential election approaches. But it...






